12:00 AM
 | 
Apr 06, 2015
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Topofen: Phase Ib/IIa data

A double-blind, crossover, U.S. Phase Ib/IIa trial in 48 patients ages 18-65 that suffer recurring moderate to severe migraines, defined as 2-8 migraines per month, with or without aura showed that topical Topofen applied over the 3 branches of the trigeminal nerve led to sustained pain relief...

Read the full 211 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >